Ignite Creation Date:
2024-05-06 @ 1:38 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04081597
Status:
WITHDRAWN
Last Update Posted:
2020-02-13
First Post:
2019-09-05
Brief Title:
A Study of Single Ascending Doses of STAR-101 in Healthy Participants
Sponsor:
Acanthas Pharma Inc
Organization:
Acanthas Pharma Inc
Study Overview
Official Title:
A Safety Tolerability and Pharmacokinetic Study of Single Ascending Doses of STAR-101 in Healthy Subjects
Status:
WITHDRAWN
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Change in Clinical Strategy
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will include a single ascending dose approach to evaluate the safety tolerability and pharmacokinetic properties of STAR-101 after a single oral administration in healthy participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None